| |
Accelerating BioVenture Innovation
|
| With Larry Schlossman (MD, BioPharma Alliances), Jahan Ali (Dir., BioVenture eLab @ Weill Cornell Medicine), David Fischell (CEO, Angel Medical Systems), Dan Heller (Head, Cancer Nanomedicine Lab), James Robinson (Prof., Weill Cornell Medicine). |
| Uris Auditorium, 1300 York Ave |
|
Sep 10 (Tue) , 2019 @ 05:30 PM
| |
FREE |
|
|
|
|
|
|
|
|
| |
| DETAILS |
|
Accelerating BioVenture Innovation
Learn about the full suite of exciting entrepreneurial initiatives & resources offered by Weill Cornell Medicine at our Fall Kickoff, including our annual 12-week course & training program in biomedical entrepreneurship, Accelerating BioVenture Innovation.
ABI builds teams around patented technologies originating from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center & Rockefeller University. The ABI entrepreneurship course & training program is organized & sponsored by Weill Cornell Medicine's BioVenture eLab & the Office of BioPharma Alliances & Research Collaborations. Participants include Principal Investigators, postdocs, graduate & medical students & serial entrepreneurs.
This event will also feature an exciting Keynote speaker-see below- & an ABI Success Story. Learn first-hand from a scientist-entrepreneur how ABI helped turn early-stage research into a successful new venture.
AGENDA
5:30pm - Registration & Networking
6:00pm - Opening Remarks
Larry Schlossman, Managing Director, BioPharma Alliances & Research Collaborations
Weill Cornell Medicine
Jahan Ali, PhD, Director, BioVenture eLab, Weill Cornell Medicine
6:15pm - Keynote Speaker
David Fischell, PhD, Chief Executive Officer, Angel Medical Systems; Chairman of the Cornell University Biomedical Engineering Advisory Board; Fellow of the American Institute for Medical & Biological Engineering; Weill Cornell Medicine Board of Overseers
6:45pm - Accelerating BioVenture Innovation Success Story
Dan Heller, PhD, Head, Cancer Nanomedicine Laboratory; Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chair; Associate Member, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center; Associate Professor, Weill Cornell Medicine, Cornell University
|
|
|
|
|
|
|
|
